[Relation of the serosal invasion mode to a recurrence in advanced gastric carcinomas].
Discussed are the attributable factors affecting the type of carcinomatous recurrence seen in 126 patients who had been operated on for their gastric carcinomas from 1979 to 1982 and who later showed a macroscopically positive serosal invasion (S0) and a histologically ss alpha approximately se invasion and required a curative resection. Forty-six percent of the patients with an ss beta approximately se invasion had a peritoneal recurrence, 21% a liver recurrence, and 33% a recurrence of some other type, whereas those with ss alpha had no such recurrence. Peritoneal recurrence tended to increase with the increase in the length of the serosal invasion and its rates were: one third in serosal invasions of less than 3 cm, one third in invasions of 3 approximately 6 cm and another third in invasions of over 6 cm. The smaller ratio of submucosal length to subserosal length, especially when less than 1.0, meant a greater frequency of peritoneal recurrence. The histologic characteristics of carcinomas that developed a peritoneal recurrence were poorly differentiated, contained INF alpha and had weaker cellular cohesion, whereas those that developed a liver metastasis were well differentiated carcinomas, contained INF beta and had a tighter cellular cohesion.
Matsusaka
T
T
Dept. of Surgery, Matsuyama Red Cross Hospital.
Wakasugi
K
K
Takenaka
M
M
Kume
K
K
Fujinaga
Y
Y
Iwashita
A
A
D002288:Adenocarcinoma, Mucinous / Q000032:analysis / Q000401:mortality / Q000473:pathology; D002277:Carcinoma / Q000032:analysis / Q000401:mortality / Q000473:pathology*; D002291:Carcinoma, Papillary / Q000032:analysis / Q000401:mortality / Q000473:pathology; D002448:Cell Adhesion; D005355:Fibrosis; D005753:Gastric Mucosa / Q000473:pathology; D006801:Humans; D007370:Interferon Type I / Q000032:analysis; D007371:Interferon-gamma / Q000032:analysis; D008113:Liver Neoplasms / Q000556:secondary; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D010534:Peritoneal Neoplasms / Q000556:secondary; D012186:Retroperitoneal Neoplasms / Q000556:secondary; D012704:Serous Membrane / Q000473:pathology; D013270:Stomach / Q000473:pathology*; D013274:Stomach Neoplasms / Q000032:analysis / Q000401:mortality / Q000473:pathology*
D007370:Interferon Type I; D007371:Interferon-gamma